Skip to content

Author

J. Krawczyk

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Beyond a cancer stem cell marker: molecular state dependent functions of CD133 and state targeted therapy

CD133 (prominin-1) is among the most widely used cancer stem cell markers, yet two decades of research have yielded persistent contradictions: CD133-negative cells can be tumorigenic, CD133-positive and -negative states can interconvert, and CD133 perturbation produces opposing phenotypes across models, while CD133 dir...

Lin Cheng, Jing-Yan Wang, Ya-Qiong Liu et al. · 0 citations
Open access Aug 2026

SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.

This first characterisation of SKY92-defined high-risk multiple myeloma in Ireland supports integrated genomic profiling for clinical risk stratification and identifies NUF2 as a promising candidate driver, demonstrating that deep profiling of high-risk disease may help to discover new targets for this challenging enti...

R. McAvera, Izabela Cymer, John P. Quinn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.